Anna N. A. Tosteson, ScD
Title(s):
Interim Director and Professor of The Dartmouth Institute
Professor of Medicine
Professor of Community and Family Medicine
James J. Carroll 1948 Professor of Oncology
Additional Titles/Positions/Affiliations:
Director, Comparative Effectiveness Research Program, The Dartmouth Institute for Health Policy and Clinical Practice
Associate Director for Population Sciences, Norris Cotton Cancer Center
Associate Director, SYNERGY, Dartmouth's Clinical and Translational Science Institute
Department(s):
The Dartmouth Institute
Medicine
Community and Family Medicine
Education:
Biostatistics (Health Decision Sciences), Harvard University, ScD
Biostatistics, Harvard University, MS
Statistics & Biometry, Cornell University, BS
Programs:
Norris Cotton Cancer Center
SYNERGY
The Dartmouth Institute for Health Policy and Clinical Practice
Contact Information:
Dartmouth Medical School
HB 7505
One Medical Center Drive
Lebanon NH 03756
Office: WTRB 526, DHMC
Phone: 603-653-3568
Email: Anna.Tosteson@dartmouth.edu
Assistant: Christopher Jacobs
Asst. Phone: 603-653-0802
Asst. Email: Christopher.R.Jacobs@Dartmouth.EDU
Professional Interests:
Dr. Anna Tosteson is a decision scientist and health services researcher who studies how the diffusion of innovations in health care are changing health, costs and quality of care. Through study of diverse data sources including registries, clinical and epidemiological studies, and administrative claims data, she seeks insights into the long-term clinical and economic effects of alternative approaches to health care delivery with a focus on cancer screening, musculoskeletal disease, and women’s health.
Grant Information:
Promoting follow-up of abnormal cancer screening tests using population-based systems to support stepped care multilevel intervention. (NCI: U01CA225451 )
Risk-based breast cancer screening and surveillance in community practice. (NCI, P01CA154292)
Courses Taught:
PH 119/121; QBS 140 Decision and Cost-Effectiveness Analysis
Selected Publications: |
|
Preoperative MRI in breast cancer: effect of breast density on biopsy rate and yield. Breast Biopsy Recommendations and Breast Cancers Diagnosed during the COVID-19 Pandemic. Reply to: Comment on: The association between neurohormonal therapy and mortality in older adults with HFrEF. Incorporating broadband durability in measuring geographic access to health care in the era of telehealth: A case example of the 2-step virtual catchment area (2SVCA) Method. Multilevel follow-up of cancer screening (mFOCUS): Protocol for a multilevel intervention to improve the follow-up of abnormal cancer screening test results. Impact of the COVID-19 Pandemic on Breast Cancer Mortality in the US: Estimates From Collaborative Simulation Modeling. Prioritizing breast imaging services during the COVID pandemic: A survey of breast imaging facilities within the Breast Cancer Surveillance Consortium. Women's considerations and experiences for breast cancer screening and surveillance during the COVID-19 pandemic in the United States: A focus group study. The association between neurohormonal therapy and mortality in older adults with heart failure with reduced ejection fraction. Association of Second-Opinion Strategies in the Histopathologic Diagnosis of Cutaneous Melanocytic Lesions With Diagnostic Accuracy and Population-Level Costs. |
|